Developing real-world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond

被引：2
|
作者：
Huo, Teh-Ia [1 ,3 ]
Liao, Jia-, I [2 ,4 ]
Ho, Shu-Yein [4 ,5 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Med Res, 201, Sec 2, Shipai Rd, Taipei 11217, Taiwan
[2] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Inst Pharmacol, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[5] Min Sheng Gen Hosp, Div Gastroenterol & Hepatol, Taoyuan, Taiwan
来源：
HEPATOLOGY INTERNATIONAL | 2023年 / 17卷 / 02期
关键词：
SCORE;
D O I：
10.1007/s12072-022-10467-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：512 / 513
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma:A retrospective,real-world study conducted in China
    Dong-Xu Wang
    Xu Yang
    Jian-Zhen Lin
    Yi Bai
    Jun-Yu Long
    Xiao-Bo Yang
    Samuel Seery
    Hai-Tao Zhao
    World Journal of Gastroenterology, 2020, (30) : 4465 - 4478
  • [22] Population Pharmacokinetic Modeling of Lenvatinib in Chinese Patients With Advanced Hepatocellular Carcinoma Using Real-World Data
    Hu, Yingying
    Chen, Ruijia
    Ye, Zhenjie
    Wei, Fuqun
    Lin, Kecan
    Liu, Jingfeng
    Zeng, Yongyi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (12): : 1507 - 1517
  • [23] Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
    Cheon, Jaekyung
    Chon, Hong Jae
    Bang, Yeonghak
    Park, Neung Hwa
    Shin, Jung Woo
    Kim, Kang Mo
    Lee, Han Chu
    Lee, Jooho
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    LIVER CANCER, 2020, 9 (05) : 613 - 624
  • [24] Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A real-world retrospective study
    Chergui, Adel
    Gadde, Eswar
    Tolu, Seda Serra
    Acuna-Villaorduna, Ana
    Kabarriti, Rafi
    Goel, Sanjay
    Kaubisch, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [25] Association between posttreatment α-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinoma
    Abou-Alfa, Ghassan K.
    Wang, Xiaoliang
    Parrinello, Christina M.
    Gossai, Anala
    Kim, Richard
    Magee, Kelly
    Miksad, Rebecca A.
    CANCER, 2023, 129 (13) : 2064 - 2074
  • [26] Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    Shimozato, Naotaka
    Namisaki, Tadashi
    Okano, Akihiro
    Ohana, Masaya
    Kinoshita, Daisuke
    Kawasaki, Toshihiko
    Aihara, Yosuke
    Nakatani, Toshiya
    Kinoshita, Hiroki
    Ann, Tatsuichi
    Saito, Ko
    Yoshida, Motoyuki
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (01) : 173 - 183
  • [27] Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination Immunotherapy
    Miwa, Chihiro
    Ogasawara, Sadahisa
    Yonemoto, Takuya
    Yumita, Sae
    Okubo, Tomomi
    Nakagawa, Miyuki
    Koroki, Keisuke
    Inoue, Masanori
    Kanogawa, Naoya
    Nakamura, Masato
    Kondo, Takayuki
    Nakamoto, Shingo
    Itokawa, Norio
    Atsukawa, Masanori
    Itobayashi, Ei
    Kato, Naoya
    CANCER MEDICINE, 2025, 14 (05):
  • [28] Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
    Bang, Yeong Hak
    Lee, Choong-kun
    Yoo, Changhoon
    Chon, Hong Jae
    Hong, Moonki
    Kang, Beodeul
    Kim, Hyung-Don
    Park, Sook Ryun
    Choi, Won-Mook
    Choi, Jonggi
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [29] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
    Wang, Dong-Xu
    Yang, Xu
    Lin, Jian-Zhen
    Bai, Yi
    Long, Jun-Yu
    Yang, Xiao-Bo
    Seery, Samuel
    Zhao, Hai-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4465 - 4478
  • [30] Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysis
    Cheon, J.
    Yoo, C.
    Bang, Y.
    Chon, H.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1308 - S1308
12345